Maximon Pharma Private Limited, a active private limited company, was established on 12 June 2018 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900DL2018PTC335210. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Employing 8 professional, Its leadership includes Sarita Kapur (Director), Harshavardhan Karunakar Hegde (Director), Akshay Kumar Saxena (Director). Past directors included Sarita Kapur, Anjali Harshavardhan Hegde, Arundhati Hegde. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No. 512 And 513 Fifth Floor Plot No. 6, Pragati Devika Tower, Nehru Place, South Delhi-110019, New Delhi, Delhi, 110019.
U74900DL2018PTC335210
335210
12 June 2018
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Maximon Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sarita Kapur | Director | 01 Aug 2021 | Current |
| Harshavardhan Karunakar Hegde | Director | 12 Jun 2018 | Current |
| Akshay Kumar Saxena | Director | 12 Jun 2018 | Current |
| Anjali Harshavardhan Hegde | Director | 01 Aug 2021 | Current |
| Rakesh Mattoo | Director | 12 Jun 2018 | Current |
| Arundhati Hegde | Director | 01 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Maximon Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.14% decrease. The company also saw a substantial fall in profitability, with a 1028.87% decrease in profit. The company's net worth observed a substantial decline by a decrease of 413.5%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Maximon Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Maximon Pharma has a workforce of 8 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Maximon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maximon Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Maximon Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Maximon Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Sarita Kapur was appointed as a Director was appointed as a Director on 01 Aug 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.
The activity Anjali Harshavardhan Hegde was appointed as a Director was appointed as a Director on 01 Aug 2021 & has been associated with this company since 4 years 5 months . was completed.
Progress on Arundhati Hegde was appointed as a Director was appointed as a Director on 01 Aug 2021 & has been associated with this company since 4 years 5 months . was documented.
Harshavardhan Karunakar Hegde was appointed as a Director was appointed as a Director on 12 Jun 2018 & has been associated with this company since 7 years 7 months . was recorded as a recent event.
The CIN of Maximon Pharma Private Limited is U74900DL2018PTC335210.
Maximon Pharma Private Limited is headquartered at No. 512 And 513 Fifth Floor Plot No. 6, Pragati Devika Tower, Nehru Place, South Delhi-110019, New Delhi, Delhi, 110019.
Maximon Pharma Private Limited was incorporated on 12 June 2018.
The current directors of Maximon Pharma Private Limited are
The primary industry of Maximon Pharma Private Limited is Trade.
Maximon Pharma Private Limited is unlisted.
The authorized capital of Maximon Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX